1. Home
  2. HUBCW vs REVBW Comparison

HUBCW vs REVBW Comparison

Compare HUBCW & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBCW
  • REVBW
  • Stock Information
  • Founded
  • HUBCW N/A
  • REVBW N/A
  • Country
  • HUBCW Israel
  • REVBW United States
  • Employees
  • HUBCW 223
  • REVBW 9
  • Industry
  • HUBCW
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBCW
  • REVBW Health Care
  • Exchange
  • HUBCW Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • HUBCW N/A
  • REVBW N/A
  • IPO Year
  • HUBCW N/A
  • REVBW 2020
  • Fundamental
  • Price
  • HUBCW $0.03
  • REVBW $0.02
  • Analyst Decision
  • HUBCW
  • REVBW
  • Analyst Count
  • HUBCW 0
  • REVBW 0
  • Target Price
  • HUBCW N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • HUBCW N/A
  • REVBW N/A
  • Earning Date
  • HUBCW N/A
  • REVBW N/A
  • Dividend Yield
  • HUBCW N/A
  • REVBW N/A
  • EPS Growth
  • HUBCW N/A
  • REVBW N/A
  • EPS
  • HUBCW N/A
  • REVBW N/A
  • Revenue
  • HUBCW N/A
  • REVBW N/A
  • Revenue This Year
  • HUBCW N/A
  • REVBW N/A
  • Revenue Next Year
  • HUBCW N/A
  • REVBW N/A
  • P/E Ratio
  • HUBCW N/A
  • REVBW N/A
  • Revenue Growth
  • HUBCW N/A
  • REVBW N/A
  • 52 Week Low
  • HUBCW N/A
  • REVBW N/A
  • 52 Week High
  • HUBCW N/A
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • HUBCW N/A
  • REVBW N/A
  • Support Level
  • HUBCW N/A
  • REVBW N/A
  • Resistance Level
  • HUBCW N/A
  • REVBW N/A
  • Average True Range (ATR)
  • HUBCW 0.00
  • REVBW 0.00
  • MACD
  • HUBCW 0.00
  • REVBW 0.00
  • Stochastic Oscillator
  • HUBCW 0.00
  • REVBW 0.00

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: